Traws Pharma (TRAW) Capital Expenditures (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Capital Expenditures of -$5000.0 for Q1 2026, down 102.54% year-over-year from $197000.0 in Q1 2025, and down 102.54% quarter-over-quarter from $197000.0 in Q1 2025.
Traws Pharma (TRAW) Capital Expenditures (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Capital Expenditures for 7 consecutive years, with -$5000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 102.54% year-over-year to -$5000.0; the TTM figure through Mar 2026 stood at $192000.0 (down 2.54% YoY), while the FY2025 annual figure was $2.6 million, down 29.14% from the prior year.
- Capital Expenditures slipped to -$5000.0 in Q1 2026 per TRAW's latest filing, from $197000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $197000.0 in Q1 2025 and bottomed at -$5000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Sep 30, 2021 | -128,000.00 |
| Sep 30, 2021 | -128,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2014 | 6,000.00 |
| Dec 31, 2014 | 6,000.00 |
| Jun 30, 2014 | 150,000.00 |
| Jun 30, 2014 | 150,000.00 |
| Mar 31, 2014 | 72,000.00 |
| Mar 31, 2014 | 72,000.00 |
| Dec 31, 2013 | 94,000.00 |
| Dec 31, 2013 | 94,000.00 |
| Sep 30, 2013 | 42,000.00 |
| Sep 30, 2013 | 42,000.00 |
| Jun 30, 2013 | 189,000.00 |
| Jun 30, 2013 | 189,000.00 |